Insider · CIK 0001457896
Ted William Karkus
Files at PRPH (ProPhase Labs, Inc.). First filing -, latest -.
In brief
Ted William Karkus files SEC Form 4 as CEO, chair and director at PRPH (ProPhase Labs, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ted William Karkus has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | PRPH ProPhase Labs, Inc. | AGrant or award warrantsderivative | +500,000 | $0.00 | $0 | 500,000 | Sep 11, 2025 |
Questions about Ted William Karkus
Answered from the filings on this page, as of the latest one.
Is Ted William Karkus buying or selling?
Ted William Karkus has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ted William Karkus's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ted William Karkus has 0.
Where does Ted William Karkus file Form 4?
Ted William Karkus has filed Form 4 at PRPH (ProPhase Labs, Inc.) as CEO & CHAIRMAN. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.